Correlation Between Lipocine and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lipocine and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Lipocine and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Catalyst Pharmaceuticals.
Diversification Opportunities for Lipocine and Catalyst Pharmaceuticals
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lipocine and Catalyst is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Lipocine i.e., Lipocine and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lipocine and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Lipocine is expected to under-perform the Catalyst Pharmaceuticals. In addition to that, Lipocine is 2.61 times more volatile than Catalyst Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.05 per unit of volatility. If you would invest 2,186 in Catalyst Pharmaceuticals on August 28, 2024 and sell it today you would lose (67.00) from holding Catalyst Pharmaceuticals or give up 3.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipocine vs. Catalyst Pharmaceuticals
Performance |
| Timeline |
| Lipocine |
| Catalyst Pharmaceuticals |
Lipocine and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and Catalyst Pharmaceuticals
The main advantage of trading using opposite Lipocine and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |